Immunic, Inc. (IMUX) Social Stream
IMMUNIC INC (IMUX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMUX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 9 | $71 | $25 | $54.125 | $1.39 | 3793.88% |
| 2022-03-03 | 8 | $71 | $25 | $54 | $1.39 | 3784.89% |
| 2022-05-13 | 7 | $71 | $25 | $54 | $1.39 | 3784.89% |
| 2022-06-02 | 7 | $64 | $25 | $49.428 | $1.39 | 3455.97% |
| 2022-06-03 | 7 | $64 | $9 | $32.428 | $1.39 | 2232.95% |
| 2022-06-06 | 6 | $40 | $9 | $24.666 | $1.39 | 1674.53% |
| 2022-08-04 | 7 | $40 | $9 | $26.857 | $1.39 | 1832.16% |
| 2022-08-05 | 7 | $40 | $9 | $26 | $1.39 | 1770.5% |
| 2022-08-08 | 7 | $40 | $9 | $25.285 | $1.39 | 1719.06% |
| 2022-10-13 | 7 | $40 | $9 | $25.428 | $1.39 | 1729.35% |
| 2022-10-21 | 7 | $40 | $5 | $24.285 | $1.39 | 1647.12% |
| 2022-11-21 | 7 | $40 | $5 | $23.857 | $1.39 | 1616.33% |
| 2023-01-18 | 6 | $39 | $5 | $21.166 | $1.39 | 1422.73% |
| 2023-02-23 | 6 | $39 | $5 | $20.833 | $1.39 | 1398.78% |
| 2023-08-04 | 6 | $35 | $5 | $19 | $1.39 | 1266.91% |
| 2023-11-15 | 5 | $28 | $5 | $13.75 | $1.39 | 889.21% |
The Trend in the Analyst Price Target
IMUX's average price target has moved down $35.75 over the prior 42 months.
IMUX reports an average of 915.78% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-16 | 6 | 35 | 5 | 19.00 | 1.70 | 1017.65% |
| 2023-07-18 | 6 | 35 | 5 | 19.00 | 2.60 | 630.77% |
| 2023-07-27 | 6 | 35 | 5 | 19.00 | 2.04 | 831.37% |
| 2023-10-10 | 5 | 28 | 5 | 13.75 | 1.37 | 903.65% |
| 2023-11-15 | 4 | 28 | 5 | 13.75 | 1.00 | 1275% |
IMUX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 17 months, IMUX's average broker recommendation rating worsened by 0.4.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, IMMUNIC INC's upside potential (average analyst target price relative to current price) is higher than 2264.52% of them.
- To contextualize these metrics, consider that out of all US stocks, IMMUNIC INC's variance in analysts' estimates is lower than -2009.26% of them.
- IMMUNIC INC's number of analysts covering the stock is greater than 1742.04% of stocks in the small market cap category.
- IMMUNIC INC's average analyst price target is higher than 1567.7% of stocks in the small market cap category.
In the Pharmaceutical Products industry, KURA, GALT, and ORIC are the three stocks most similar to IMMUNIC INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for IMUX? Use POWR Ratings for clearer insight into price direction.